Our study revealed that several cytokines and biomarkers were significantly increased in infected SARS-CoV-2 patients with severe form of the disease in comparison to those who were not, which was accompanied with coagulopathy as determined by deterioration of the platelet related parameters (PLR, D-dimer, IL-6) and MCP-1 as thrombosis related indicator. The gene discussed is CCL2; the disease is blood coagulation disease.